Affiliated Faculty
This list of affiliated investigators can help you identify potential research mentors at the University of Pittsburgh. PSTP students can, and do, work with mentors not on this list, but the investigators featured below have expressed interest in hosting PSTP students in their laboratories.
Tissue Engineering and Regenerative Medicine, emphasis upon clinical application; Cell:biomaterial interactions; Epimorphic regeneration in mammals
The Bailey laboratory focuses on the intersection of DNA damage and immunobiology in Ewing sarcoma, a primary bone tumor diagnosed in adolescents.
Identify phosphorylations, dephosphorylations and acetylations that regulate ATM activity in vivo
Neurophysiology of sensory-motor coordination, brain-machine interfaces
Investigation of the molecular mechanisms that regulate the pathogenesis of genetic and acquired cardiomyopathies
Dr. Benam is the founder of Translational and Multidisciplinary Lung Microengineering Lab, which brings together researchers from the engineering, biology, bio-pharmaceutical industry, clinical and business communities with the aim of developing new technologies that recreate complex human organ pathophysiology in vitro, and applying them to discover novel therapeutics and personalized biomarkers. His research focuses on applying disruptive technologies that enable him and his team to elucidate cellular and molecular mechanisms that govern tissue pathology or offer protection during lung injury and host-environment interaction.
The Billiar Lab focuses on the immune responses to acute systemic stresses of major clinical relevance including trauma and surgical sepsis
The mechanisms of cross-priming of antigens during immune responses to cancer, viruses and autoimmunity
Demand adapted hematopoiesis in infection and inflammation
Research in the Brieño-Enríquez lab focuses on the regulation of gametogenesis and reproductive aging in mammals (human, mouse and naked mole-rat) and, more specifically, the fundamental mechanisms that are required to produce viable germ cells and maintain them along the lifespan.
Protein “quality control”, diseases associated with misfolded proteins, and drug treatments for these diseases
Tumor microenvironment, Cancer stem cells, novel therapeutics for cancer
Development of targeted therapies for KRAS mutant NSCLC; Reactivation of OIS and apoptosis; Mechanisms of acquired resistance to targeted agents
Gene therapy, viral vector engineering, genome editing, inherited retinal degeneration, genetics of eye disease